Formulation Development

Formurex strategically designs and develops customized formulations that are robust, scalable, and manufacturable, tailored to the unique physicochemical properties of each compound. Our formulation team applies Quality by Design (QbD) principles, Design of Experiments (DOE), and risk-based approaches to ensure efficient and reproducible product and process development. We also offer capabilities for handling controlled substances (Class II to V), potent compounds, and specialized formulations, including pediatric and geriatric dosage forms.

Drug Delivery Systems

• Oral Extended-Release Formulations
• Buccal/Sublingual Formulations
• Gastroretentive Formulations
• Transdermal Formulations
• Self-Emulsifying Formulations
• Easy-to-Swallow Formulations
• Vaginal Formulations
• Abuse-Deterrent Formulations
• Ophthalmic Formulations
• Topical Formulations
• Parenteral Formulations
• Drug-Device Combinations

Processes and Formulations

Processes

• Direct Compression
• Dry Compression/Roller Compaction
• Wet Granulation (High shear, fluid bed granulation)
• Tablet Compression (Single/bilayer)
• Coating (Perforated coating, fluid bed coating)

Tablet Formulations

• Conventional Oral Tablets
• Extended-Release Tablets
• Mouth-Dissolving Tablets
• Orally Disintegrating Tablets
• Effervescence Tablets
• Chewable Tablets
• Bioadhesive Tablets
• Mini Tablets

Capsule Formulations

• Powder Filled Capsules
• Granules Filled Capsules
• Spheroids Filled Capsules
• Mini-Tablets Filled Capsules
• Extended-release Capsules

Dry Powder Formulations

• Amorphous Solid Dispersions for Solubility Enhancement
• Dry Powders for Inhalation
• Micro particles for Extended Release

Liquid Formulations

• Solutions for Oral and Parenteral
• Suspensions for Oral
• Nano Suspensions for Oral and Parenteral
• Emulsions/Micro and/or Nanoemulsions for Oral and Parenteral
• Syrups for Oral

Topical Dosage Formulations

• Gels
• Creams
• Ointments